Labroots

test NGS testing and the single day sequencing workflow

Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic ...
Nasdaq

Quest Diagnostics (DGX) Expands Testing Suite With NGS Test

Quest Diagnostics Incorporated DGX recently announced that the company is now offering the liquid biopsy-based Target Selector NGS Lung Panel test developed by Biocept BIOC. The addition of this blood ...
Labroots

Beyond the noise: Identifying clinically relevant mutations in somatic NGS testing

Next-generation sequencing (NGS) allows the simultaneous analysis of multiple genomic alterations with therapeutic implications, paving the way for precision medicine and transforming cancer care.
Business Wire

Thermo Fisher Scientific & Pfizer Partner to Expand Localized Access to Next-Generation Sequencing-Based Testing for Cancer Patients in International Markets

Increasing localized access can provide faster results for patients while potentially improving patient outcomes Agreement aims to enable greater access to localized advanced testing capabilities for ...
Business Wire

QIAGEN’s Clinical Decision Support Platform QCI Surpasses Three Million NGS Patient Test Cases

REDWOOD CITY, Calif. & HILDEN, Germany--(BUSINESS WIRE)--QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) today announced that its decision-support software platform QIAGEN Clinical Insights (QCI) ...
The American Journal of Managed Care

Dr Melissa Johnson Discusses Barriers to NGS Testing in Lung Cancer

Melissa Johnson, MD, program director of Lung Cancer Research at Sarah Cannon, explains factors inhibiting uptake of next-generation sequencing testing among patients with lung cancer. Recent years ...
The American Journal of Managed Care

Dr Jennifer Gass Provides an Overview of FCS' Next-Generation Sequencing Laboratory

Jennifer Gass, PhD, FACMG, associate director, Genetics Laboratory, Florida Cancer Specialists & Research Institute, discusses the recent Genetics Laboratory, which focuses on next-generation ...
MedPage Today

EGFR Testing in Advanced NSCLC: Real-World Data Show Major Gaps

"Clinicians performing tumor biopsy need to ensure that there’s adequate tissue for both diagnosis and NGS testing. Having immediate pathology review of biopsy specimens in the operating room can ...
Kaleido Scope

NEXT GEN SEQUENCING AND DELETION/DUPLICATION ANALYSIS OF NF1 ONLY (NF1-NG)

Patients with classic NF1 including the presence of cutaneous neurofibromas or Lisch nodules, as no genetic heterogeneity demonstrated so far associated with this phenotype. The NF1-only by NGS ...
MarketWatch

Pillar Biosciences' FDA Approved Solid Tumor NGS Kit oncoReveal(TM) CDx Launched at Molecular Pathology Laboratory Network, Inc.

NATICK, Mass., July 30, 2024 /PRNewswire/ -- Pillar Biosciences, Inc., the leader in Decision Medicine(TM), has announced that Molecular Pathology Laboratory Network, Inc., (MPLN) is now the first ...
Kaleido Scope

Meningiomatosis/Multiple meningiomas Panel by NGS

Patients with multiple schwannomas w/wo vestibular schwannomas. This testing approach is developed to diagnose mosaic NF2, classic NF2, Schwannomatosis, and mosaic schwannomatosis. The Meningiomatosis ...